Biomarker Identifies Patients With Advanced Lung Cancer Who Will Gain Most From Add-On Cetuximab
December 22nd 2011Investigators reported that high tumor EGFR expression is a predictive biomarker that defines patients with advanced NSCLC who are most likely to derive a survival benefit from the addition of cetuximab to platinum-based, first-line chemotherapy.
Read More
One-Carbon Nutrient Supplements May Boost Risk of Type II Endometrial Cancer
July 7th 2011New data suggest that, contrary to expectation, the use of supplements containing one-carbon nutrients like folate and vitamins B2, B6, and B12 appears to be associated with an increased risk of type II endometrial cancer.
Read More
Patient Navigation Boosts Colorectal Cancer Screening Rate in Ethnically Diverse Patients
July 1st 2011A recent study showed that a patient-navigation-based intervention may help increase the rate of CRC screening in typically underserved groups, including low-income, ethnically diverse patients.
Read More
Chemoradiotherapy Before Surgery May Prolong Survival in Locally Advanced Lung Cancer
June 9th 2011Patients with node-negative, locally advanced lung tumors who undergo induction chemoradiotherapy appear to survive significantly longer than patients who undergo surgical resection without induction chemoradiotherapy
Read More